Showing results (91-100 of 237) with videos related to

Sort By:
Pageof 24
Oncology Reports|April 26, 2017
AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifierMasahiro Seike, Cheol-Hong Kim, Fenfei Zou, et al.
Journal of Thoracic Disease|August 3, 2019
Impact of clinical features on the efficacy of osimertinib therapy in patients with T790M-positive non-small cell lung cancer and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitorsYasuhiro Kato, Yukio Hosomi, Kageaki Watanabe, et al.
International Journal of Clinical Oncology|March 4, 2021
Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutationsYasuhiro Kato, Gou Yamamoto, Yasutaka Watanabe, et al.
Anticancer Research|January 29, 2018
Association Between Clinicopathological Features and Programmed Death Ligand 1 Expression in Non-small Cell Lung CancerYasuhiro Kato, Jumpei Kashima, Kageaki Watanabe, et al.
International Journal of Oncology|July 4, 2012
MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cellsMengru Cao, Masahiro Seike, Chie Soeno, et al.
International Journal of Clinical Oncology|May 12, 2023
Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective studyShinji Nakamichi, Kaoru Kubota, Fenfei Zou, et al.
Radiology Case Reports|April 22, 2024
Interstitial lung disease with prolonged fever that occurred during long-term administration of olaparib in a 74-year-old ovarian cancer patient: Radiological features and considerations for preventing delayed diagnosisYoshinobu Saito, Rei Yamaguchi, Takahiro Suzuki, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|April 11, 2022
Effectiveness of Corticosteroid Therapy for Non-Severe COVID-19 in Patients Not Requiring Supplemental Oxygen Who Have Risk Factors for Severe DiseaseToru Tanaka, Yoshinobu Saito, Takeru Kashiwada, et al.
Translational Lung Cancer Research|September 15, 2025
Effect of type 2 diabetes mellitus on systemic treatment for advanced non-small cell lung cancerYasuhiro Kato, Eri Kuramochi, Rei Yamaguchi, et al.
Internal Medicine (Tokyo, Japan)|July 3, 2024
Streptococcal Toxic Shock Syndrome with Multiple Cerebral Infarctions Caused by Streptococcus dysgalactiae subsp. equisimilis: An Autopsy Case ReportSho Saito, Namiko Taniuchi, Norio Motoda, et al.
Pageof 24